These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 18209726

  • 1. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.
    Craddock CF.
    Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726
    [Abstract] [Full Text] [Related]

  • 2. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Lekakis L, de Lima M.
    Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Optimizing the conditioning regimen for allogeneic stem-cell transplantation in acute myeloid leukemia; dose intensity is still in need.
    Shimoni A, Nagler A.
    Best Pract Res Clin Haematol; 2011 Sep; 24(3):369-79. PubMed ID: 21925090
    [Abstract] [Full Text] [Related]

  • 5. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D, Martino R.
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic haemopoietic stem cell transplantation using non-myeloablative conditioning--a local experience.
    Leong CF, Cheong SK, Fadilah SA, Ainoon O, Hamidah NH.
    Med J Malaysia; 2003 Jun; 58(2):229-35. PubMed ID: 14569743
    [Abstract] [Full Text] [Related]

  • 7. Can reduced-intensity allogeneic transplantation cure older adults with AML?
    Storb R.
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):85-90. PubMed ID: 17336258
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome.
    de Lima M, Giralt S.
    Semin Hematol; 2006 Apr; 43(2):107-17. PubMed ID: 16616044
    [Abstract] [Full Text] [Related]

  • 9. Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?
    Song KW, Lipton J.
    Bone Marrow Transplant; 2005 Aug; 36(3):183-91. PubMed ID: 15937497
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.
    Niederwieser D, Gentilini C, Hegenbart U, Lange T, Becker C, Wang SY, Bartsch K, Pönisch W, Raida M, Al-Ali H.
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):275-81. PubMed ID: 16213741
    [Abstract] [Full Text] [Related]

  • 11. Reduced intensity conditioning (RIC) haematopoietic cell transplants in elderly patients with AML.
    Niederwieser D, Lange T, Cross M, Basara N, Al-Ali H.
    Best Pract Res Clin Haematol; 2006 Nov; 19(4):825-38. PubMed ID: 16997186
    [Abstract] [Full Text] [Related]

  • 12. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C, Meijer E, Petersen EJ, Lokhorst HM, Verdonck LF.
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):181-6. PubMed ID: 18215778
    [Abstract] [Full Text] [Related]

  • 13. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
    Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO, Wilmot F, McCarthy PL, Hahn T.
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
    [Abstract] [Full Text] [Related]

  • 14. High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
    Schmid C, Schleuning M, Hentrich M, Markl GE, Gerbitz A, Tischer J, Ledderose G, Oruzio D, Hiddemann W, Kolb HJ.
    Bone Marrow Transplant; 2008 Apr; 41(8):721-7. PubMed ID: 18176613
    [Abstract] [Full Text] [Related]

  • 15. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.
    Al-Ali H, Cross M, Lange T, Freund M, Dölken G, Niederwieser D.
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 17. Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.
    Cahu X, Mohty M, Faucher C, Chevalier P, Vey N, El-Cheikh J, Guillaume T, Furst S, Delaunay J, Ayari S, Moreau P, Gastaut JA, Harousseau JL, Blaise D.
    Bone Marrow Transplant; 2008 Nov; 42(10):689-91. PubMed ID: 18679370
    [No Abstract] [Full Text] [Related]

  • 18. Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'.
    Kassim AA, Chinratanalab W, Ferrara JL, Mineishi S.
    Bone Marrow Transplant; 2005 Oct; 36(7):565-74. PubMed ID: 15995714
    [Abstract] [Full Text] [Related]

  • 19. [Mini-transplant for acute myeloblastic leukemia and myelodysplastic syndrome].
    Kanda Y.
    Nihon Rinsho; 2003 Sep; 61(9):1565-72. PubMed ID: 14515725
    [Abstract] [Full Text] [Related]

  • 20. [Non-myeloablative allogeneic stem cell transplantation].
    Dalgaard J, Fløisand Y, Stenersen M, Egeland T, Brinch L.
    Tidsskr Nor Laegeforen; 2007 Mar 15; 127(6):721-4. PubMed ID: 17363982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.